US 10913946
RNA modulating oligonucleotides with improved characteristics for the treatment of Duchenne and Becker muscular dystrophy
granted A61PA61P21/00A61P43/00
Quick answer
US patent 10913946 (RNA modulating oligonucleotides with improved characteristics for the treatment of Duchenne and Becker muscular dystrophy) held by BIOMARIN TECHNOLOGIES B.V. expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOMARIN TECHNOLOGIES B.V.
- Grant date
- Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61P, A61P21/00, A61P43/00